Friday, November 27, 10:55 am IST
Hot Searches:  mahindra satyamITCtata steel
| Feedback
Moneycontrol » News Center » Business » Earnings
Aventis Pharma Q1 PAT seen at Rs 36.3 cr: Motilal Oswal
Published on Sat, Jul 04, 2009 at 16:30   |  Updated at Sat, Jul 04, 2009 at 16:38  |  Source : Moneycontrol.com

Motilal Oswal has come out with its earning estimates on Pharmaceuticals Sector for the quarter ended June 2009. According to the research firm, Aventis Pharma's June quarter sales are expected to go down by 6.3% to Rs 233.1 crore on YoY basis.

The company's adjusted PAT (profit after tax) is expected to go down by 13.2% to Rs 36.3 crore on YoY basis.


More news from Brokerage Results Estimates

What's your Opinion

WHAT OTHERS LIKE
  • Most Read
  • Most Viewed
24 Hours
7 Days
1 Month
NEWS FROM OUR PARTNERS
©Network 18, 2009. All Rights Reserved